Your browser doesn't support javascript.
loading
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.
Lee, Lennard Y W; Ionescu, Maria C; Starkey, Thomas; Little, Martin; Tilby, Michael; Tripathy, Arvind R; Mckenzie, Hayley S; Al-Hajji, Youssra; Appanna, Nathan; Barnard, Matthew; Benny, Liza; Burnett, Alexander; Cattell, Emma L; Clark, James J; Khan, Sam; Ghafoor, Qamar; Panneerselvam, Hari; Illsley, George; Harper-Wynne, Catherine; Hattersley, Rosie J; Lee, Alvin Jx; Lomas, Oliver; Liu, Justin Kh; McCauley, Amanda; Pang, Matthew; Pascoe, Jennifer S; Platt, James R; Patel, Grisma; Patel, Vijay; Potter, Vanessa A; Randle, Amelia; Rigg, Anne S; Robinson, Tim M; Roques, Tom W; Roux, René L; Rozmanowski, Stefan; Taylor, Harriet; Tuthill, Mark H; Watts, Isabella; Williams, Sarah; Beggs, Andrew; Iveson, Tim; Lee, Siow M; Middleton, Gary; Middleton, Mark; Protheroe, Andrew; Fittall, Matthew W; Fowler, Tom; Johnson, Peter.
Afiliación
  • Lee LYW; Department of Oncology, University of Oxford; Institute of Cancer and Genomic Sciences, University of Birmingham; Institute of Immunology and Immunotherapy, University of Birmingham. Electronic address: lennard.lee@oncology.ox.ac.uk.
  • Ionescu MC; UK Health Security Agency (UKHSA).
  • Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham.
  • Little M; Department of Oncology, Oxford University Hospitals NHS Foundation Trust.
  • Tilby M; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust.
  • Tripathy AR; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust.
  • Mckenzie HS; Oncology Department, University Hospitals Southampton NHS Foundation Trust.
  • Al-Hajji Y; Birmingham Medical School, University of Birmingham.
  • Appanna N; University of Oxford.
  • Barnard M; University of Oxford.
  • Benny L; UK Health Security Agency (UKHSA).
  • Burnett A; Sheffield Teaching Hospitals NHS Foundation Trust.
  • Cattell EL; Department of Cancer, Taunton and Somerset NHS Foundation Trust.
  • Clark JJ; Department of Surgery and Cancer, Imperial College London.
  • Khan S; Leicester Cancer Research Centre, University of Leicester.
  • Ghafoor Q; University Hospitals Birmingham NHS Foundation Trust.
  • Panneerselvam H; Department of Oncology, Wye Valley NHS Foundation Trust.
  • Illsley G; UK Health Security Agency (UKHSA).
  • Harper-Wynne C; Kent Oncology Centre, Kent and Medway Medical School, University of Kent.
  • Hattersley RJ; Department of Oncology, Torbay Hospital NHS Foundation Trust.
  • Lee AJ; UCL Cancer Institute, University College London; University College London Hospitals NHS Trust.
  • Lomas O; Department of Oncology, Oxford University Hospitals NHS Foundation Trust.
  • Liu JK; Leeds Institute of Medical Research at St James's, University of Leeds.
  • McCauley A; UK Health Security Agency (UKHSA).
  • Pang M; UK Department of Health and Social Care (DHSC).
  • Pascoe JS; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust.
  • Platt JR; Leeds Institute of Medical Research at St James's, University of Leeds.
  • Patel G; Cancer Division, UCL Cancer Institute, University College London.
  • Patel V; NHS England.
  • Potter VA; Department of Oncology, University Hospital Coventry and Warwickshire.
  • Randle A; Royal College of Physicians.
  • Rigg AS; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust.
  • Robinson TM; Population Health Sciences, University of Bristol.
  • Roques TW; Cancer Services, Norfolk and Norwich University Hospitals NHS Foundation Trust.
  • Roux RL; Department of Oncology, Oxford University Hospitals NHS Foundation Trust.
  • Rozmanowski S; Cancer Division, UCL Cancer Institute, University College London.
  • Taylor H; Oxford Medical School, University of Oxford.
  • Tuthill MH; Department of Oncology, Oxford University Hospitals NHS Foundation Trust.
  • Watts I; Department of Academic Oncology, Royal Free Hospital.
  • Williams S; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust.
  • Beggs A; Institute of Cancer and Genomic Sciences, University of Birmingham.
  • Iveson T; Cancer Sciences, University of Southampton.
  • Lee SM; UCL Cancer Institute, University College London; University College London Hospitals NHS Trust; CRUK Lung Cancer Centre of Excellence, University College London.
  • Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust.
  • Middleton M; Department of Oncology, University of Oxford.
  • Protheroe A; Department of Oncology, Oxford University Hospitals NHS Foundation Trust.
  • Fittall MW; Cancer Division, UCL Cancer Institute, University College London.
  • Fowler T; UK Health Security Agency (UKHSA).
  • Johnson P; Department of Oncology, University Hospital Coventry and Warwickshire; Cancer Sciences, University of Southampton.
Eur J Cancer ; 175: 1-10, 2022 11.
Article en En | MEDLINE | ID: mdl-36084618
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido